1、Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy:
An update on risk factors, pathophysiology and imaging modalities[ J].
Prog Retin Eye Res, 2020, 79: 100865.Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy:
An update on risk factors, pathophysiology and imaging modalities[ J].
Prog Retin Eye Res, 2020, 79: 100865.
2、Daruich A, Matet A, Behar-Cohen F. Central serous chorioretinopathy[ J].
Dev Ophthalmol, 2017, 58: 27-38.Daruich A, Matet A, Behar-Cohen F. Central serous chorioretinopathy[ J].
Dev Ophthalmol, 2017, 58: 27-38.
3、Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy:
Recent findings and new physiopathology hypothesis[ J]. Prog Retin
Eye Res, 2015, 48: 82-118.Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy:
Recent findings and new physiopathology hypothesis[ J]. Prog Retin
Eye Res, 2015, 48: 82-118.
4、Shinojima A, Hirose T, Mori R, et al. Morphologic findings in acute
central serous chorioretinopathy using spectral domain-optical
coherence tomography with simultaneous angiography[ J]. Retina,
2010, 30(2): 193-202.Shinojima A, Hirose T, Mori R, et al. Morphologic findings in acute
central serous chorioretinopathy using spectral domain-optical
coherence tomography with simultaneous angiography[ J]. Retina,
2010, 30(2): 193-202.
5、Ahn SJ, Kim TW, Huh JW, et al. Comparison of features on SD-OCT
between acute central serous chorioretinopathy and exudative age-
related macular degeneration[ J]. Ophthalmic Surg Lasers Imaging,
2012, 43(5): 374-382.Ahn SJ, Kim TW, Huh JW, et al. Comparison of features on SD-OCT
between acute central serous chorioretinopathy and exudative age-
related macular degeneration[ J]. Ophthalmic Surg Lasers Imaging,
2012, 43(5): 374-382.
6、Lehmann M, Wolff B, Vasseur V, et al. Retinal and choroidal
changes observed with ‘En face’ enhanced-depth imaging OCT
in central serous chorioretinopathy[ J]. Br J Ophthalmol, 2013,
97(9): 1181-1186.Lehmann M, Wolff B, Vasseur V, et al. Retinal and choroidal
changes observed with ‘En face’ enhanced-depth imaging OCT
in central serous chorioretinopathy[ J]. Br J Ophthalmol, 2013,
97(9): 1181-1186.
7、Chung YR, Kim JW, Kim SW, et al. Choroidal thickness in patients
with central serous chorioretinopathy: assessment of Haller and Sattler
layers[ J]. Retina, 2016, 36(9): 1652-1657.Chung YR, Kim JW, Kim SW, et al. Choroidal thickness in patients
with central serous chorioretinopathy: assessment of Haller and Sattler
layers[ J]. Retina, 2016, 36(9): 1652-1657.
8、Chung Y, Kim JW, Choi S, et al. Subfoveal choroidal thickness
and vascular diameter in active and resolved central serous
chorioretinopathy[ J]. Retina, 2018, 38(1): 102-107.Chung Y, Kim JW, Choi S, et al. Subfoveal choroidal thickness
and vascular diameter in active and resolved central serous
chorioretinopathy[ J]. Retina, 2018, 38(1): 102-107.
9、Staurenghi G, Sadda S, Chakravarthy U, et al. Proposed lexicon
for anatomic landmarks in normal posterior segment spectral-
domain optical coherence tomography: the IN?OCT consensus[ J].
Ophthalmology, 2014, 121(8): 1572-1578.Staurenghi G, Sadda S, Chakravarthy U, et al. Proposed lexicon
for anatomic landmarks in normal posterior segment spectral-
domain optical coherence tomography: the IN?OCT consensus[ J].
Ophthalmology, 2014, 121(8): 1572-1578.
10、Branchini LA, Adhi M, Regatieri CV, et al. Analysis of choroidal
morphologic features and vasculature in healthy eyes using spectral-
domain optical coherence tomography[ J]. Ophthalmology, 2013,
120(9): 1901-1908.Branchini LA, Adhi M, Regatieri CV, et al. Analysis of choroidal
morphologic features and vasculature in healthy eyes using spectral-
domain optical coherence tomography[ J]. Ophthalmology, 2013,
120(9): 1901-1908.
11、Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment
epitheliopathy[ J]. Retina, 2013, 33(8): 1659-1672.Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment
epitheliopathy[ J]. Retina, 2013, 33(8): 1659-1672.
12、Cheung C, Lee WK, Koizumi H, et al. Pachychoroid disease[ J]. Eye
(Lond), 2019, 33(1): 14-33.Cheung C, Lee WK, Koizumi H, et al. Pachychoroid disease[ J]. Eye
(Lond), 2019, 33(1): 14-33.
13、Fujimoto H, Gomi F, Wakabayashi T, et al. Morphologic changes in
acute central serous chorioretinopathy evaluated by fourier-domain
optical coherence tomography[ J]. Ophthalmology, 2008, 115(9):
1494-1500, 1500-1501.Fujimoto H, Gomi F, Wakabayashi T, et al. Morphologic changes in
acute central serous chorioretinopathy evaluated by fourier-domain
optical coherence tomography[ J]. Ophthalmology, 2008, 115(9):
1494-1500, 1500-1501.
14、Hirami Y, Tsujikawa A, Sasahara M, et al. Alterations of retinal pigment
epithelium in central serous chorioretinopathy[ J]. Clin Experiment
Ophthalmol, 2007, 35(3): 225-230.Hirami Y, Tsujikawa A, Sasahara M, et al. Alterations of retinal pigment
epithelium in central serous chorioretinopathy[ J]. Clin Experiment
Ophthalmol, 2007, 35(3): 225-230.
15、Gupta V, Gupta P, Dogra MR, et al. Spontaneous closure of retinal
pigment epithelium microrip in the natural course of central serous
chorioretinopathy[ J]. Eye (Lond), 2010, 24(4): 595-599.Gupta V, Gupta P, Dogra MR, et al. Spontaneous closure of retinal
pigment epithelium microrip in the natural course of central serous
chorioretinopathy[ J]. Eye (Lond), 2010, 24(4): 595-599.
16、Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial
detachment[ J]. Surv Ophthalmol, 2007, 52(3): 227-243.Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial
detachment[ J]. Surv Ophthalmol, 2007, 52(3): 227-243.